Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
Clinical trial NCT06372626 · RECRUITING
Trial details
- NCT number
- NCT06372626
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2026-07-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.